ClinVar Genomic variation as it relates to human health
NM_000117.3(EMD):c.130C>T (p.Gln44Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000117.3(EMD):c.130C>T (p.Gln44Ter)
Variation ID: 11176 Accession: VCV000011176.10
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: Xq28 X: 154379737 (GRCh38) [ NCBI UCSC ] X: 153608097 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jun 29, 2015 May 1, 2024 Oct 15, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000117.3:c.130C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000108.1:p.Gln44Ter nonsense NC_000023.11:g.154379737C>T NC_000023.10:g.153608097C>T NG_008677.1:g.10302C>T LRG_745:g.10302C>T LRG_745t1:c.130C>T LRG_745p1:p.Gln44Ter - Protein change
- Q44*
- Other names
-
Q43*
NP_000108.1:p.Gln44*
- Canonical SPDI
- NC_000023.11:154379736:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
EMD | - | - |
GRCh38 GRCh37 |
540 | 807 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
criteria provided, single submitter
|
Oct 15, 2023 | RCV000011926.7 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Apr 25, 2023 | RCV000078128.10 | |
Pathogenic (1) |
criteria provided, single submitter
|
Nov 17, 2020 | RCV002381248.3 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 15, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
X-linked Emery-Dreifuss muscular dystrophy
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003445291.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Gln44*) in the EMD gene. It is expected to result in an absent or disrupted protein … (more)
This sequence change creates a premature translational stop signal (p.Gln44*) in the EMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Emery-Dreifuss muscular dystrophy (PMID: 8595406). This variant is also known as 188C>T. ClinVar contains an entry for this variant (Variation ID: 11176). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Jul 25, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
unknown
|
Molecular Diagnostics Lab, Nemours Children's Health, Delaware
Accession: SCV000590864.1
First in ClinVar: Jun 29, 2015 Last updated: Jun 29, 2015 |
Observation 1:
Age: 20-29 years
Sex: male
Observation 2:
Age: 50-59 years
Sex: male
|
|
Pathogenic
(Sep 10, 2013)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000109966.8
First in ClinVar: Jan 17, 2014 Last updated: Jun 29, 2015 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Pathogenic
(Apr 25, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV003921760.1
First in ClinVar: May 06, 2023 Last updated: May 06, 2023 |
Comment:
Not observed in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function … (more)
Not observed in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 21993399, 30079154, 31718017, 10377322, 9472006, 9536090, 31683627, 8595406, 21697856, 10382909) (less)
|
|
Pathogenic
(Nov 17, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002694311.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The p.Q44* pathogenic mutation (also known as c.130C>T), located in coding exon 2 of the EMD gene, results from a C to T substitution at … (more)
The p.Q44* pathogenic mutation (also known as c.130C>T), located in coding exon 2 of the EMD gene, results from a C to T substitution at nucleotide position 130. This mutation has been detected in males affected with Emery-Dreifuss muscular dystrophy, including several from a single family, as well as in at least one carrier female with cardiac findings (Brown CA et al. J Hum Genet, 2011 Aug;56:589-94; Carboni N et al. Neuromuscul Disord, 2012 Feb;22:152-8; Viggiano E et al. Genes (Basel), 2019 11;10:[Epub ahead of print]). In addition to the clinical data presented in the literature, this changes the amino acid from a glutamine to a stop codon within coding exon 2. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. (less)
|
|
Pathogenic
(Oct 01, 1995)
|
no assertion criteria provided
Method: literature only
|
EMERY-DREIFUSS MUSCULAR DYSTROPHY, X-LINKED
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000032159.2
First in ClinVar: Apr 04, 2013 Last updated: Aug 29, 2016 |
Comment on evidence:
Klauck et al. (1995) identified novel mutations in 3 families with Emery-Dreifuss muscular dystrophy (310300). One of these was a C-to-T transition at nucleotide 188, … (more)
Klauck et al. (1995) identified novel mutations in 3 families with Emery-Dreifuss muscular dystrophy (310300). One of these was a C-to-T transition at nucleotide 188, resulting in a change of codon 43 from CAG (gln) to a stop codon. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers. | Viggiano E | Genes | 2019 | PMID: 31718017 |
Obesity and pericallosal lipoma in X-linked emery-dreifuss muscular dystrophy: A case report - Does Emerin play a role in adipocyte differentiation? | Spanu F | World journal of radiology | 2018 | PMID: 30079154 |
Emerin in health and disease. | Koch AJ | Seminars in cell & developmental biology | 2014 | PMID: 24365856 |
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy. | Carboni N | Neuromuscular disorders : NMD | 2012 | PMID: 21993399 |
Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot. | Brown CA | Journal of human genetics | 2011 | PMID: 21697856 |
Identification of novel mutations in three families with Emery-Dreifuss muscular dystrophy. | Klauck SM | Human molecular genetics | 1995 | PMID: 8595406 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=EMD | - | - | - | - |
Text-mined citations for rs132630262 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.